Summary: S.2669 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for S.2669. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (04/16/2018)

Advancing Innovation in Alternative Pain and Addiction Therapies Act

This bill requires the Food and Drug Administration to issue guidance clarifying eligibility and criteria for the accelerated approval of non-opioid or nonaddictive drugs to treat pain or substance-use disorders.